Mitogenic effect of oxidized low-density lipoprotein on vascular smooth muscle cells mediated by activation of Ras/Raf/MEK/MAPK pathway

Neuroscience

• Mitogen-Activated Protein Kinase 100%
• Oxidized Low Density Lipoprotein 100%
• Vascular Smooth Muscle 100%
• Mitogen Activated Protein Kinase 3 41%
• phosphorylation 33%
• Cell Proliferation 25%
• DNA Synthesis 25%
• Platelet-Derived Growth Factor 16%
• P38 Mitogen-Activated Protein Kinases 8%
• Tyrosine Kinase Inhibitor 8%
• Thapsigargin 8%
• Staurosporine 8%
• Herbimycin 8%
• Thymidine 8%
• Pertussis Toxin 8%
• G Protein Coupled Receptor 8%
• Risk Factor 8%
• Genistein 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Mitogen Activated Protein Kinase 100%
• Oxidized Low Density Lipoprotein 100%
• Mitogen Activated Protein Kinase 3 41%
• Thymidine 33%
• Platelet Derived Growth Factor 16%
• Rat 16%
• Mitogen Activated Protein Kinase P38 8%
• Atherosclerosis 8%
• 2 (2 Amino 3 Methoxyphenyl)chromone 8%
• Genistein 8%
• Ethylene Glycol 1,2 Bis(2 Aminophenyl) Ether N,n,n',n' Tetraacetic Acid 8%
• 1 [[6 (3 Methoxyestra 1,3,5(10) Trien 17beta Yl)amino]hexyl] 1h Pyrrole 2,5 Dione 8%
• Protein Tyrosine Kinase Inhibitor 8%
• SB 203580 8%
• Staurosporine 8%
• Pertussis Toxin 8%
• Herbimycin A 8%
• G Protein Coupled Receptor 8%
• Thapsigargin 8%